Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    ZINC584641429

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    FDA Approves 5 New Costly Drugs Well Ahead of PDUFA Dates
    FDA Approves 5 New Costly Drugs Well Ahead of PDUFA Dates

    27 Nov 2019

    // Z. Brennan RAPS

    https://www.raps.org/news-and-articles/news-articles/2019/11/fda-approves-5-new-costly-drugs-well-ahead-of-acti

    Z. Brennan RAPS
    27 Nov 2019
    Share Share
    Catalent, BeiGene Enter Long-Term Supply Agreement
    Catalent, BeiGene Enter Long-Term Supply Agreement

    21 Nov 2019

    // CONTRACT PHARMA

    https://www.contractpharma.com/contents/view_breaking-news/2019-11-21/catalent-beigene-enter-long-term-supply-agreement/

    CONTRACT PHARMA
    21 Nov 2019
    Share Share
    BeiGene nabs landmark FDA nod for Brukinsa, kicking off challenge against blockbuster Imbruvica
    BeiGene nabs landmark FDA nod for Brukinsa, kicking off challenge against blockbuster Imbruvica

    16 Nov 2019

    // Angus Liu FIERCE PHARMA

    https://www.fiercepharma.com/marketing/beigene-nabs-landmark-fda-nod-for-brukinsa-kicking-off-challenge-against-blockbuster

    Angus Liu FIERCE PHARMA
    16 Nov 2019
    Share Share
    China's BeiGene scores FDA approval but can they carve up J&J's blockbuster
    China's BeiGene scores FDA approval but can they carve up J&J's blockbuster

    14 Nov 2019

    // Natalie Grover ENDPTS

    https://endpts.com/chinas-beigene-scores-first-ever-fda-approval-but-can-they-carve-up-jjs-blockbuster-franchise/

    Natalie Grover ENDPTS
    14 Nov 2019
    Share Share
    BeiGene hits back at short seller's accusations of 60% sales inflation
    BeiGene hits back at short seller's accusations of 60% sales inflation

    10 Sep 2019

    // Angus Liu FIERCE PHARMA

    https://www.fiercepharma.com/pharma-asia/false-statements-and-wild-speculations-beigene-hits-back-at-accusations-60-sales

    Angus Liu FIERCE PHARMA
    10 Sep 2019
    Share Share
    BeiGene & Mustang nail down special FDA status for top drugs
    BeiGene & Mustang nail down special FDA status for top drugs

    23 Aug 2019

    // John Carroll ENDPTS

    https://endpts.com/beigene-and-mustang-nail-down-special-fda-status-for-top-drugs-roche-bags-added-coverage-for-hemlibra/

    John Carroll ENDPTS
    23 Aug 2019
    Share Share